계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Angiotech Pharmaceuticals
company
About
Angiotech is a Vancouver, British Columbia pharmaceutical company.
- 1001 - 5000
Highlights
Details
- Last Funding Type
- Series Unknown
- Industries
- Health Care,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 1989
- Number Of Employee
- 1001 - 5000
- Operating Status
- Active
Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Angiotech Pharmaceuticals has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Mar 21, 2017 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 21, 2017 | Series Unknown | — | 4 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
Angiotech Pharmaceuticals is funded by 4 investors.
Cathay Venture
and Fung Shing Investments
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
China Orient Asset Management (International) Holding
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
